12. Net Loss Per Share
Basic and diluted loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average common shares outstanding (in thousands, except share and per share data):
THREE MONTHS ENDED MARCH 31, | ||||||
| 2022 |
| 2021 | |||
Numerator: | ||||||
Net loss | $ | (10,497) | $ | (4,473) | ||
Net loss attributable to common stockholders - basic and diluted | $ | (10,497) | $ | (4,473) | ||
Denominator: |
|
| ||||
Weighted-average common stock outstanding - basic and diluted |
| 38,247,970 |
| 912,222 | ||
Net loss per share attributable to common stockholders - basic and diluted | $ | (0.27) | $ | (4.90) | ||
The Company’s potentially dilutive securities, which include preferred stock, unvested restricted common stock, unvested RSUs and stock options, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders for the three months ended March 31, 2022 and 2021 because including them would have had an anti-dilutive effect:
THREE MONTHS ENDED MARCH 31, | |||||
| 2022 |
| 2021 |
| |
Preferred Stock | — | 25,475,905 | |||
Unvested restricted stock |
| 744,615 |
| 740,406 |
|
Unvested RSUs | 35,900 | — | |||
Options to purchase common stock | 6,820,843 | 2,034,953 | |||
| 7,601,358 |
| 28,251,264 |
| |
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!
